| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/20/2003 | WO2003014986A2 Method for predicting the formation of mould fungi |
| 02/20/2003 | WO2003014879A2 System and method for identifying a genetic risk factor for a disease or pathology |
| 02/20/2003 | WO2003014746A2 Method for identifying proteins with n-terminal n-myristoylation |
| 02/20/2003 | WO2003014745A2 Method for identifying anti-inflammatory drugs |
| 02/20/2003 | WO2003014744A2 Method and diagnostic kit for diagnosing helicobacter pylori |
| 02/20/2003 | WO2003014743A2 Use of dendrimers and poly-branched molecules to enhance signal in fluorescent assay systems |
| 02/20/2003 | WO2003014733A2 Methods and markers for identifying activated synapses |
| 02/20/2003 | WO2003014731A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 02/20/2003 | WO2003014724A1 A novel cancer marker and uses therefor in the diagnosis of cancer |
| 02/20/2003 | WO2003014722A1 Nucleic acid field effect transistor |
| 02/20/2003 | WO2003014721A2 Chimeric protein and its use in electron transfer methods |
| 02/20/2003 | WO2003014708A1 Identification of particles in fluid |
| 02/20/2003 | WO2003014704A2 Rapid and specific detection of campylobacter |
| 02/20/2003 | WO2003014703A2 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | WO2003014699A2 Compositions and methods for detecting and quantifying cox-2 activity by lipoamino acid metabolism |
| 02/20/2003 | WO2003014698A2 Biological assay detection method |
| 02/20/2003 | WO2003014695A2 Biosensor and method for detecting macromolecular biopolymers by means of at least one unit for immobilizing macromolecular biopolymers |
| 02/20/2003 | WO2003014402A2 Method for identification of type specific polynucleotide sequences |
| 02/20/2003 | WO2003014401A1 Methods for the identification of inhibitors of ferredoxin nadp oxidoreductase expression or activity in plants |
| 02/20/2003 | WO2003014399A1 Method of haplotyping and kit therefor |
| 02/20/2003 | WO2003014398A2 Methods and compositions for mutation detection by liquid chromatography |
| 02/20/2003 | WO2003014397A1 Probe for detection of enteric virus detection kit and method for enteric virus with the same |
| 02/20/2003 | WO2003014396A1 Diagnosis method of multiplication disease of trinucleotide repeated sequence and a diagnosis kit |
| 02/20/2003 | WO2003014395A1 Method of examining bronchial asthma |
| 02/20/2003 | WO2003014394A1 Method of evaluating biocompatibility |
| 02/20/2003 | WO2003014393A1 METHOD OF DETECTING, IDENTIFYING AND COUNTING ENTERITIS VIBRIO USING GENE (rpoD) SEQUENCES ENCODING RNA POLYMERASE σ70 FACTOR |
| 02/20/2003 | WO2003014392A2 Use and evaluation of a [2+2] photoaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix |
| 02/20/2003 | WO2003014391A2 Method for the detection of a polymorphism in cpb2 |
| 02/20/2003 | WO2003014390A2 Screening methods and sequences relating thereto |
| 02/20/2003 | WO2003014389A2 Method for determining susceptibility to prion disease |
| 02/20/2003 | WO2003014388A2 Method and nucleic acids for the analysis of colon cancer |
| 02/20/2003 | WO2003014387A2 Polymorphisms in the human gene for cyp1a2 and their use in diagnostic and therapeutic applications |
| 02/20/2003 | WO2003014386A2 Method for identifying macrocyclic polyketides |
| 02/20/2003 | WO2003014385A1 A novel method for eliminating repeat sequence in genome and its use in preparing of fish probe |
| 02/20/2003 | WO2003014384A1 A novel method for eliminating repeat sequence in genome and its use in genome chips |
| 02/20/2003 | WO2003014383A2 Phenotypic effects of ubiquinone deficiencies and methods of screening thereof |
| 02/20/2003 | WO2003014382A2 Device for analyzing nucleic acid |
| 02/20/2003 | WO2003014381A1 System for detecting protease |
| 02/20/2003 | WO2003014380A2 Microoroganisms and cells for diagnosis and therapy of tumors |
| 02/20/2003 | WO2003014379A2 Improved method and composition for determining resistance to an acetohydroxyacid synthase inhibitor |
| 02/20/2003 | WO2003014378A2 Amperometric biosensor in thick film technology |
| 02/20/2003 | WO2003014377A2 Competitive binding assay for identifying inhibitors of hcv polymerase |
| 02/20/2003 | WO2003014375A2 Nucleic acid sensor molecules and methods of using same |
| 02/20/2003 | WO2003014369A1 Nucleic acid ligands with intramolecular duplexes |
| 02/20/2003 | WO2003014366A2 Rna amplification system using plant components in animal cells |
| 02/20/2003 | WO2003014357A1 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/20/2003 | WO2003014353A2 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 02/20/2003 | WO2003014346A2 High-throughput dna-isolation and transfection for analysing the function of genes or genetic products |
| 02/20/2003 | WO2003014345A1 Gene panel participating in liver astrocyte activation |
| 02/20/2003 | WO2003014343A1 Method for analyzing inhibition of ftsz polymerization using fluorescence assay technique |
| 02/20/2003 | WO2003014342A2 Identification of a dna variant associated with adult type hypolactasia |
| 02/20/2003 | WO2003014341A2 Chimeric proteins comprising a haem domain of a mammalian or plant cytochrome p450 and a scaffold-reductase domain from p450 bm3 of bacillus megaterium and uses thereof |
| 02/20/2003 | WO2003014334A1 Cell culture method for obtaining prostate-like acini |
| 02/20/2003 | WO2003014333A1 Use of lysyl oxidase inhibitors for cell culture and tissue engineering |
| 02/20/2003 | WO2003014323A2 Human smooth muscle myosin heavy chain |
| 02/20/2003 | WO2003014322A2 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | WO2003014321A2 Compositions and methods for modulation of darpp-32 phosphorylation |
| 02/20/2003 | WO2003014319A2 Polymorphisms associated with multiple sclerosis |
| 02/20/2003 | WO2003014303A2 Molecular interactions in cells |
| 02/20/2003 | WO2003014301A2 Hprp4s as modifiers of the p53 pathway and methods of use |
| 02/20/2003 | WO2003014300A2 TRPS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/20/2003 | WO2003014299A2 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 02/20/2003 | WO2003014298A2 Full-length prostate selective polynucleotides and polypeptides |
| 02/20/2003 | WO2003014295A2 Method and system for identifying splice variants of a gene |
| 02/20/2003 | WO2003014294A2 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | WO2003014291A1 Device and methods for detecting the response of a plurality of cells to at least one analyte of interest |
| 02/20/2003 | WO2003014153A2 Cellular virus receptors and methods of use. |
| 02/20/2003 | WO2003014151A2 Human secreted proteins, their encoding polynucleotides, and uses thereof |
| 02/20/2003 | WO2003014149A2 Genetically modified cyclic-nucleotide controlled ion channels and the use thereof |
| 02/20/2003 | WO2003014145A2 Peptides that bind to atherosclerotic lesions |
| 02/20/2003 | WO2003014143A2 Haplotype map of the human genome and uses therefor |
| 02/20/2003 | WO2003014142A2 Phosphorylated histone h2b as an apoptosis marker |
| 02/20/2003 | WO2003014140A1 Compositions, methods and products comprising human papillomavirus for detecting and treating a cancer |
| 02/20/2003 | WO2003014077A2 Crystal forms and mutants of rank ligand |
| 02/20/2003 | WO2003013603A1 Modulators of p-selectin glycoprotein ligand 1 |
| 02/20/2003 | WO2003013590A1 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 02/20/2003 | WO2003013551A1 G protein-coupled receptor assay |
| 02/20/2003 | WO2003013537A2 Irinotecan for treatment of cancer |
| 02/20/2003 | WO2003013536A2 Methods for treatment of cancer using irinotecan based on ugt1a1 |
| 02/20/2003 | WO2003013535A2 Use of irinotecan for improved treatment of cancer based on mdr1 |
| 02/20/2003 | WO2003013534A2 Methods for the treatment of cancer with irinotecan based on cyp3a5 |
| 02/20/2003 | WO2003013533A2 Methods for improved treatment of cancer with irinotecan based on mrp1 |
| 02/20/2003 | WO2003013431A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 02/20/2003 | WO2003013424A2 Use of r-nsaid compounds for anti-hiv treatment |
| 02/20/2003 | WO2003013346A2 Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
| 02/20/2003 | WO2003013224A2 Herbicide tolerant cotton plants and methods for producing and identifying same |
| 02/20/2003 | WO2003002733A3 Compositions for enhanced catalyzed reporter deposition |
| 02/20/2003 | WO2003000851A3 Method for rapid screening of bacterial transformants and novel simian adenovirus proteins |
| 02/20/2003 | WO2002103060A9 Enterovirus nucleic acids and methods for detecting enterovirus |
| 02/20/2003 | WO2002101084A3 Scintillation proximity assays for aminoglycoside binding molecules |
| 02/20/2003 | WO2002099386A3 Microcalorimetric detection of analytes and binding events |
| 02/20/2003 | WO2002099381A3 A single-cell biosensor for the measurement of gpcr ligands in a test sample |
| 02/20/2003 | WO2002099138A3 HS2STs AS MODIFIERS OF THE P53 PATHWAY AND METHODS OF USE |
| 02/20/2003 | WO2002096262A3 Non-alloying core shell nanoparticles |
| 02/20/2003 | WO2002095057A3 Pairs of nucleic acid probes with interactive signaling moieties and nucleic acid probes with enhanced hybridization efficiency and specificity |
| 02/20/2003 | WO2002094874A3 Internalisation of virus into cells |
| 02/20/2003 | WO2002094862A3 Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 02/20/2003 | WO2002092769A3 System for discovery of agents that block yersinia pestis and pseudomonas aeruginosa dna replication |
| 02/20/2003 | WO2002090924A3 Mutation induced optimization of receptor signal to noise ratio |
| 02/20/2003 | WO2002090516A3 Design of artificial genes for use as controls in gene expression analysis systems |